bibliographic resource 578271 [br/578271]
https://w3id.org/oc/corpus/br/578271

is a

• document
• article

title

• Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma

publication date

• 2013-01-01

contributor

• https://w3id.org/oc/corpus/ar/1778362
• https://w3id.org/oc/corpus/ar/1778363
• https://w3id.org/oc/corpus/ar/1778364

format

• https://w3id.org/oc/corpus/re/243913

identifier

• https://w3id.org/oc/corpus/id/911499
• https://w3id.org/oc/corpus/id/911500
• https://w3id.org/oc/corpus/id/911501
• https://w3id.org/oc/corpus/id/911502

part of

• https://w3id.org/oc/corpus/br/108615